1. Home
  2. MRSN vs MDBH Comparison

MRSN vs MDBH Comparison

Compare MRSN & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • MDBH
  • Stock Information
  • Founded
  • MRSN 2001
  • MDBH 1997
  • Country
  • MRSN United States
  • MDBH United States
  • Employees
  • MRSN N/A
  • MDBH N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • MDBH
  • Sector
  • MRSN Health Care
  • MDBH
  • Exchange
  • MRSN Nasdaq
  • MDBH Nasdaq
  • Market Cap
  • MRSN 34.0M
  • MDBH 40.5M
  • IPO Year
  • MRSN 2017
  • MDBH 2023
  • Fundamental
  • Price
  • MRSN $6.75
  • MDBH $3.88
  • Analyst Decision
  • MRSN Strong Buy
  • MDBH
  • Analyst Count
  • MRSN 5
  • MDBH 0
  • Target Price
  • MRSN $5.75
  • MDBH N/A
  • AVG Volume (30 Days)
  • MRSN 130.5K
  • MDBH 2.7K
  • Earning Date
  • MRSN 08-12-2025
  • MDBH 08-12-2025
  • Dividend Yield
  • MRSN N/A
  • MDBH N/A
  • EPS Growth
  • MRSN N/A
  • MDBH N/A
  • EPS
  • MRSN N/A
  • MDBH 0.84
  • Revenue
  • MRSN $34,006,000.00
  • MDBH $3,574,131.00
  • Revenue This Year
  • MRSN N/A
  • MDBH N/A
  • Revenue Next Year
  • MRSN $1.03
  • MDBH N/A
  • P/E Ratio
  • MRSN N/A
  • MDBH $4.87
  • Revenue Growth
  • MRSN N/A
  • MDBH N/A
  • 52 Week Low
  • MRSN $6.47
  • MDBH $3.61
  • 52 Week High
  • MRSN $70.75
  • MDBH $11.99
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 38.74
  • MDBH 40.03
  • Support Level
  • MRSN $6.55
  • MDBH $3.91
  • Resistance Level
  • MRSN $10.25
  • MDBH $4.68
  • Average True Range (ATR)
  • MRSN 0.70
  • MDBH 0.26
  • MACD
  • MRSN -0.20
  • MDBH -0.07
  • Stochastic Oscillator
  • MRSN 5.41
  • MDBH 6.90

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Share on Social Networks: